After reviewing available evidence and the GRADE evaluation for use of CVD 103-HgR, ACIP voted in June 2016 to recommend use of lyophilized CVD 103-HgR vaccine in adults 18–64 years old traveling to areas of active toxigenic V. cholerae O1 transmission (recommendation Category A). See Recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of cholera vaccine.

Background paper Americas United States of America Cholera